Literature DB >> 33513793

Strategies to Get Drugs across Bladder Penetrating Barriers for Improving Bladder Cancer Therapy.

Shupeng Wang1, Shaohua Jin1, Qinghai Shu1, Song Wu2.   

Abstract

Bladder cancer is a significant public health concern and social burden due to its high recurrence risk. Intravesical drug instillation is the primary therapy for bladder cancer to prevent recurrence. However, the intravesical drug therapeutic effect is limited by bladder penetrating barriers. The inadequate intravesical treatment might cause the low drug concentration in lesions, resulting in a high recurrence/progression rate of bladder cancer. Many strategies to get drugs across bladder penetrating barriers have been developed to improve intravesical treatment, including physical and chemical methods. This review summarizes the classical and updated literature and presents insights into great therapeutic potential strategies to overcome bladder penetrating barriers for improving the intravesical treatment of bladder cancer.

Entities:  

Keywords:  bladder cancer; bladder mucosa; bladder penetrating barriers; drug instillation; intravesical treatment; urothelium

Year:  2021        PMID: 33513793     DOI: 10.3390/pharmaceutics13020166

Source DB:  PubMed          Journal:  Pharmaceutics        ISSN: 1999-4923            Impact factor:   6.321


  5 in total

1.  Modified Titanium Dioxide as a Potential Visible-Light-Activated Photosensitizer for Bladder Cancer Treatment.

Authors:  Thaiane Robeldo; Lucas S Ribeiro; Lida Manrique; Andressa Mayumi Kubo; Elson Longo; Emerson Rodrigues Camargo; Ricardo Carneiro Borra
Journal:  ACS Omega       Date:  2022-05-18

Review 2.  Mucoadhesive Polymers and Their Applications in Drug Delivery Systems for the Treatment of Bladder Cancer.

Authors:  Caroline S A de Lima; Justine P R O Varca; Victória M Alves; Kamila M Nogueira; Cassia P C Cruz; M Isabel Rial-Hermida; Sławomir S Kadłubowski; Gustavo H C Varca; Ademar B Lugão
Journal:  Gels       Date:  2022-09-15

3.  Values of OAS gene family in the expression signature, immune cell infiltration and prognosis of human bladder cancer.

Authors:  Lijuan Gao; Ruimin Ren; Jing Shen; Jiayi Hou; Junya Ning; Yanlin Feng; Meiyue Wang; Lifei Wu; Yaojun Sun; Huang Wang; Deping Wang; Jimin Cao
Journal:  BMC Cancer       Date:  2022-09-26       Impact factor: 4.638

Review 4.  Impact of Effective Intravesical Therapies on Quality of Life in Patients with Non-Muscle Invasive Bladder Cancer: A Systematic Review.

Authors:  John W Yuen; Ricky W Wu; Shirley S Ching; Chi-Fai Ng
Journal:  Int J Environ Res Public Health       Date:  2022-08-30       Impact factor: 4.614

Review 5.  Nanotechnology in Bladder Cancer: Diagnosis and Treatment.

Authors:  Mahmood Barani; Seyedeh Maryam Hosseinikhah; Abbas Rahdar; Leila Farhoudi; Rabia Arshad; Magali Cucchiarini; Sadanand Pandey
Journal:  Cancers (Basel)       Date:  2021-05-05       Impact factor: 6.639

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.